Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disease characterized by skin fibrofolliculomas, pulmonary cysts, spontaneous pneumothoraces, and renal cancers. Oncocytomas are benign epithelial tumors that are also rare. Recently, there have been a few case reports of BHD with a parotid oncocytoma that appears to have a BHD phenotype. Here we document the eighth known case and describe the magnetic resonance imaging features of the parotid oncocytoma, which mimicked Warthin's tumor. Radiologists should be aware of the association between these rare disorders.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008813PMC
http://dx.doi.org/10.1155/2018/6265175DOI Listing

Publication Analysis

Top Keywords

parotid oncocytoma
12
birt-hogg-dubé syndrome
8
oncocytoma manifestation
4
manifestation birt-hogg-dubé
4
syndrome birt-hogg-dubé
4
syndrome bhd
4
bhd rare
4
rare autosomal
4
autosomal dominant
4
dominant disease
4

Similar Publications

Article Synopsis
  • Oncocytoma is a rare, benign tumor of the salivary glands, making up less than 2% of all salivary tumors, typically presenting as swelling and rarely recurring.
  • A systematic review analyzed 147 case reports, finding that the average patient was 58.7 years old, with the parotid gland being the most commonly affected, and treatment mainly involved excisional biopsy.
  • The review also noted a slight female predominance in cases and a low association with Birt-Hogg-Dube syndrome, alongside a generally indolent course with few recurrences.
View Article and Find Full Text PDF

Background/aim: Parotid oncocytomas typically present as benign, unilateral, slow-growing, painless, and solitary masses that are histologically firm and multilobulated. They are often misdiagnosed as pleomorphic adenomas, hemangiomas, or other forms of oncocytosis. However, in our case, the parotid oncocytomas initially mimicked bilateral parotid gland metastasis of advanced oropharyngeal cancer.

View Article and Find Full Text PDF

Low Radiation Doses in Oncocytic Lesions of the Parotid Gland: A Double-edged Sword. A Comprehensive Review.

Ann Ital Chir

August 2024

Radiation Oncology Unit, Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, 98125 Messina, Italy.

Article Synopsis
  • - Oncocytic lesions are benign or precancerous tumors in the parotid gland, characterized by large, granular cells, and their diagnosis typically relies on imaging techniques and fine-needle aspiration (FNA) biopsy for histopathological examination.
  • - Treatment options include surgery, conservative management, and radiation therapy (RT), but low doses of radiation can paradoxically encourage the growth of these lesions.
  • - The prognosis for patients is usually good when lesions are benign and managed well, with ongoing research exploring the molecular effects of low-dose radiation on these tumors.
View Article and Find Full Text PDF
Article Synopsis
  • * A systematic review analyzed 16 patients and families with BHDS, revealing a majority were middle-aged, with skin fibrofolliculomas present in most cases and notable occurrences of oral and parotid lesions, particularly oncocytomas.
  • * Due to the rarity of BHDS, its diverse clinical signs may often go unnoticed, highlighting the importance of renal screening for patients showing signs of the syndrome, especially those with oncocytic parotid
View Article and Find Full Text PDF

Facial nerve injury is one of the most substantial potential sequelae of parotid surgery. Pulling, stretching, and otherwise disturbing the facial nerve during parotid surgery can lead to post-surgical neural paresis and consequential deficits in facial movement. Furthermore, transection of the main facial nerve trunk or its branches, either purposeful or incidental, can lead to complete paralysis of the related facial musculature.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!